Natus Medical (BABY) Misses Q3 EPS by 2c, Offers Q4 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts BABY Hot Sheet
Price: $26.75 --0%
Financial Fact:
Income from operations: 15.24M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Financial Fact:
Income from operations: 15.24M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Natus Medical (NASDAQ: BABY) reported Q3 EPS of $0.40, $0.02 worse than the analyst estimate of $0.42. Revenue for the quarter came in at $130.6 million versus the consensus estimate of $132.92 million.
GUIDANCE:
Natus Medical sees Q4 2018 EPS of $0.48-$0.51, versus the consensus of $0.54. Natus Medical sees Q4 2018 revenue of $135-140 million, versus the consensus of $138.04 million.
For earnings history and earnings-related data on Natus Medical (BABY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- AI-powered cyber threats light a fire under cybersecurity stocks
- Meta's capital-raising plans expose a major weakness in the AI boom
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
